Barriers and facilitators to the use of medications for opioid use disorder: a rapid review

K Mackey, S Veazie, J Anderson, D Bourne… - Journal of general …, 2020 - Springer
Background Despite evidence that medications to treat opioid use disorder (OUD) are
effective, most people who could benefit from this treatment do not receive it. This rapid …

Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective

NY Hall, L Le, I Majmudar, C Mihalopoulos - Drug and alcohol dependence, 2021 - Elsevier
Objectives To update the existing evidence to identify specific barriers to initiation of opioid
substitution therapy (OST) for those with opioid use disorder (OUD). Methods The review …

Update on barriers to pharmacotherapy for opioid use disorders

A Sharma, SM Kelly, SG Mitchell, J Gryczynski… - Current psychiatry …, 2017 - Springer
Abstract Purpose of Review The recent heroin and prescription opioid misuse epidemic has
led to a sharp increase in the number of opioid overdose deaths in the USA …

[HTML][HTML] Buprenorphine in the United States: Motives for abuse, misuse, and diversion

HD Chilcoat, HR Amick, MR Sherwood… - Journal of Substance …, 2019 - Elsevier
Opioid use disorder (OUD) and its consequences are a major public health concern. The
partial agonist buprenorphine is a safe and effective treatment for OUD, but concerns about …

America's opioid crisis: the need for an integrated public health approach

C Blanco, TRA Wiley, JJ Lloyd, MF Lopez… - Translational …, 2020 - nature.com
Continued increases in overdose deaths and recent declines in life expectancy call for need
to adopt comprehensive public health approaches to the United States opioid crisis and to …

Buprenorphine dispensing in an epicenter of the US opioid epidemic: a case study of the rural risk environment in Appalachian Kentucky

HLF Cooper, DH Cloud, PR Freeman… - International Journal of …, 2020 - Elsevier
Background Buprenorphine is a cornerstone to curbing opioid epidemics, but emerging data
suggest that rural pharmacists in the US sometimes refuse to dispense this medication. We …

Knowledge, preparedness, and compassion fatigue among law enforcement officers who respond to opioid overdose

JJ Carroll, S Mital, J Wolff, RK Noonan… - Drug and alcohol …, 2020 - Elsevier
Background Rates of fatal overdose (OD) from synthetic opioids rose nearly 60% from 2016
to 2018. 911 Good Samaritan Laws (GSLs) are an evidenced-based strategy for preventing …

[HTML][HTML] Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises

LD Wenger, AH Kral, RN Bluthenthal, T Morris… - Translational …, 2021 - Elsevier
As COVID-19 accelerated throughout 2020, syringe service programs (SSPs) faced
challenges necessitating programmatic adaptations to prevent overdose deaths while …

Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco

J Carter, B Zevin, PJ Lum - Addiction science & clinical practice, 2019 - Springer
Background Opioid overdose is a leading cause of death in persons experiencing
homelessness (PEH), despite effective medications for opioid use disorder (OUD). In 2016 …

Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature

A Jakubowski, S Fowler, AD Fox - Addiction science & clinical practice, 2023 - Springer
Abstract Background Syringe services programs (SSPs) provide a spectrum of health
services to people who use drugs, with many providing referral and linkage to substance …